Company Profile - Natera Inc

Introduction

Natera Inc (Natera), formerly Gene Security Network LLC, develops genetic and cell-free deoxyribonucleic acid (cfDNA) testing solutions. The company’s products include Signatera, a personalized ctDNA (circulating tumor DNA) blood test to assess MRD (molecular residual disease) and its recurrence; Aletra, a tissue-based genomic profiling test to identify genomic alterations and oncology biomarkers in a tumor; Prospera, a transplant rejection test to evaluate the risk of rejection of a transplanted kidney. It also offers Renasight test to detect genetic cause of kidney diseases; Horizon carrier screening test; Panorama non-invasive prenatal screening test; Empower hereditary cancer test; Vistara prenatal single gene screening test; Anora miscarriage test; and Spectrum preimplantation genetic test. Natera is headquartered in Austin, Texas, the US.